Health
Hims & Hers Buys Lab to Expand Into At-Home Blood Testing
- Hims shares have soared on demand for copycat obesity drugs
- Purchase of Sigmund brings test kits for hormones, cholesterol
This article is for subscribers only.
Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the acquisition of a home blood-testing company.
The telehealth provider purchased Sigmund NJ LLC, which uses a US-approved device for home testing of hormones, cholesterol and other markers of health, according to a statement on Wednesday. New Jersey-based Sigmund markets its services as Trybe Labs. Terms of the deal weren’t disclosed.